Evosep ApS: Financial statements 2018
CVR: 37510068
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Evosep ApS (CVR 37510068) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,509,519 and a net result of DKK -4,951,102 compared with DKK -8,613,473 the year before. Equity in the 2018 report amounted to DKK 22,510,339. The solvency ratio was 91.2%.
- Gross Profit
- DKK 2,509,519
- Profit/Loss
- DKK -4,951,102
- Equity
- DKK 22,510,339
- Total Assets
- DKK 24,685,964
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.5 mio. | -5 mio. | 22.5 mio. | - |
| 2017 | - | -2.7 mio. | -8.6 mio. | 7.2 mio. | - |
| 2016 | - | -1.2 mio. | -4.2 mio. | 7.9 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Evosep ApS has published its annual report for 2017. Gross profit came to DKK -2,722,228, and the net result was DKK -8,613,473.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity in the 2025 report amounted to DKK 154,548,000.